Market Notice
There is currently a price interruption. If it is a product with a single price fixing on the day, please note the underlying trading model. Trading is not possible at the moment.
Biomarin Pharmaceutical Inc./Faktor/Long [4]/MS
Product class
Factor with KO - Factor Warrant - with KO with Leverage
Last exchange day
Open End
Performance (1M)
32.47%
Basis price
44.3425 [USD]
Knock-Out barrier
44.3425 [USD]
Leverage
4.00
Multiplier
0.0772
Distance to KO barrier absolute
14.87 USD
Distance to KO barrier in %
25.11 %
Agio p.a. in %
-
Factor
4.00
Ø Tradable bid size main / secondary
0/0
Ø Tradable ask size main / secondary
0/0
Spread main / secondary
0.00/0.00
Tax presence main / secondary
-/-
Trade further knock-out products for BioMarin Pharmaceutical Inc. without exchange fees.
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 08:42:16 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 1.04 | 0.99 |
| PREV. DAY'S PRICE | 1.02 | (07/20) |
| CHANGE DAY BEFORE | -0.02 | -1.96 % |
| 52 WEEK HIGH / LOW | 3.15 (08/05) | 0.57 (05/18) |
Indicators
| TIME OF CALCULATION | 04:22:18 AM (07/22/2026) |
| AGIO P.A. IN % | - |
| LEVERAGE | 4.00 |
| DISTANCE TO KNOCK-OUT BARRIER ABSOLUTE | 14.87 USD |
| DISTANCE TO KNOCK-OUT BARRIER IN % | 25.11 % |
Master Data
| WKN | MJ1BZ9 |
| ISIN | DE000MJ1BZ99 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Leverage Product |
| PRODUCT CLASS | Factor with KO - Factor Warrant - with KO with Leverage |
| PRODUCT NAME | Faktor 4x Long BioMarin emittiert von Morgan Stanley & Co. Int. plc |
| ISSUER | Morgan Stanley & Co. International plc |
| TRADING SEGMENT | EASY EUWAX |
| OPTION TYPE | call |
| UNDERLYING | BIOMARIN PHARMACEUTICAL USD0.001 |
| BASIS PRICE | 44.3425 [USD] |
| KNOCKOUT BARRIER | 44.3425 [USD] |
| KNOCKIN LEVEL | - [-] |
| FACTOR | 4.00 |
| RANGE | - - - |
| MULTIPLIER | 0.0772 |
| EXERCISE TYPE | American |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | EUR |
| SETTLEMENT CURRENCY | Euro |
| SMALLEST TRADABLE UNIT | 1.00 |
| MINIMUM QUOTATION EUR | 10,000.00 |
| MINIMUM QUOTATION UNITS | 10,000.00 |
| LAST VALUATION DAY | Open End |
| PAYMENT DATE | - |
| FIRST EXCHANGE DAY | 18/09/2024 |
| LAST EXCHANGE DAY | Open End |
| TRADING HOURS | 08:00:00 AM - 10:00:00 PM |
| QUOTATION | fortlaufende Auktion |
| ISSUE VOLUME | 2,650,000 |
| ROLLING | No |
| QUANTO | No |
Underlying
| WKN | 924801 |
| ISIN | US09061G1013 |
| SYMBOL | BM8 |
| NOMINAL CURRENCY | Euro |
| TYPE OF UNDERLYING | Equity |
| COUNTRY OF THE HOME STOCK EXCHANGE | Germany |
Issuer
| NAME | Morgan Stanley & Co. International plc |
| ADDRESS | Morgan Stanley & Co. International plc
25 Cabot Square, Canary Wharf
E14 4QA London
Großbritannien |
| EMAIL ADDRESS | strukturierte-produkte@morganstanley.com |
| SERVICE PHONE NUMBER | 069 21661234 |
| URL | https://zertifikate.morganstanley.com/ |
| DOCUMENTS | PRIIP / KID (english) |
| ISSUER PORTRAIT | PDF |
Product Description
This factor warrant provides the investor with a constant leverage of 4.00 to participate in the positive and negative performance of the Biomarin Pharmaceutical Inc., which is the underlying instrument. This product has an unlimited term. The issuer has the right to terminate the warrant, subject to a specific notice period.